Navigation Links
Cambrex Reports Third Quarter 2009 Results
Date:11/3/2009

68.2% 42,057 74.5% ------- ------- Gross Profit 16,948 29.3% 16,235 28.7% Operating Expenses Selling, General and Administrative Expenses 9,295 16.1% 8,767 15.5% Research and Development Expenses 2,026 3.5% 1,772 3.1% Restructuring Expenses - 0.0% 321 0.6% Strategic Alternative Costs - 0.0% 833 1.5% ------- ------- Total Operating Expenses 11,321 19.6% 11,693 20.7% ------- ------- Operating Profit 5,627 9.7% 4,542 8.0% Other Expenses/(Income): Interest Expense, net 1,111 1.9% 956 1.7% Other (Income)/Expense, net (31) -0.1% 485 0.8% ------- ------- Income Before Income Taxes 4,547 7.9% 3,101 5.5% Provision for Income Taxes 1,584 2.8% 304 0.6% ------- ------- Net Income $2,963 5.1% $2,797 4.9% ======= ======= Earnings per Share of Common Stock Basic $0.10 $0.10 Diluted $0.10 $0.10 Weighted Average Shares Outstanding Basic 29,253 29,163 Diluted 29,303 29,178 CAMBREX CORPORATION Statement of Profit and Loss For the Nine Months Ended September 30, 2009 and 2008 (in thousands) 2009 200
'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)...  Insulet Corporation (NASDAQ: PODD ), the leader ... Insulin Management System, today announced that Dr. ... of Directors. Dr. Hopfield brings more than ... Board. She currently serves as the Vice Chair of ... largest diabetes research center, diabetes clinic, and provider of ...
(Date:7/28/2015)... 2015   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... quarter ended June 30, 2015 on Tuesday, August 4, ... Regulus will host a conference call and webcast ... Daylight Time to discuss its second quarter 2015 financial ...
(Date:7/28/2015)... Mass., July 28, 2015  Psychemedics Corporation (NASDAQ: ... the period ended June 30, 2015.  The Company also ... to shareholders of record as of August 7, 2015 ... be the Company,s 76 th consecutive quarterly dividend. ... June 30, 2015 was $7.0 million versus $7.7 million ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8
... Genmab Initiates a Phase I/II Study of Zalutumumab in ... Advanced Head and Neck Cancer., COPENHAGEN, June 24 ... a Phase I/II study of zalutumumab,(HuMax-EGFr(TM)) in combination with ... The study will include a maximum of 36,patients who ...
... Biopharmaceuticals Plc, a,biopharmaceutical company focused on the development ... initiated a Phase II,equivalent study of MRX-4, in ... allergic rhinitis (AR). The two-arm, randomized, multi-dose,double-blind, placebo-controlled ... study is expected to be completed by the ...
Cached Medicine Technology:Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis 2
(Date:7/28/2015)... , ... July 29, 2015 , ... ... Susan Bentley as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation's leading networking organization exclusively for professional women, boasting more ...
(Date:7/28/2015)... ... , ... Every July, since 2007, about 25 pediatric pulmonary hypertension (PH) patients ... television. They go to summer camp. , PH is incurable and life threatening, as ... pushes hard to get blood through arteries in the lungs narrowed by the disease. ...
(Date:7/28/2015)... ... July 28, 2015 , ... Jordan Valley Medical ... With The Guidelines®-Stroke Gold Plus Award for implementing specific quality improvement measures outline ... , The Get With The Guidelines-Stroke program recognizes hospitals that demonstrate at least ...
(Date:7/28/2015)... Hollywood, Fl (PRWEB) , ... July 28, 2015 ... ... opened its new Total Heart Center at Memorial Regional Hospital, providing expert, streamlined ... 19,000-square-foot center will be suited to provide extensive heart services under one roof, ...
(Date:7/28/2015)... Rosa, California (PRWEB) , ... July 28, 2015 , ... Santa Rosa’s The Press Democrat ... year in a row, Dr. Francisco Canales and Dr. Heather Furnas took the top spot ... the community, Dr. Furnas and Dr. Canales are proud to be bestowed such a prestigious ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Susan Bentley, Owner of Women's Wellness Options, Into its VIP Woman of the Year Circle 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2
... may be increasing the drug resistance across the world., ... in the journal The Lancet, worldwide resistance to drugs ... 12% since the mid-nineties., ,Adamantanes have been used ... 30 years. Previous surveillance studies have identified a low ...
... companies, said Wednesday it had tied up with private ... over 100 cities. // , ,Under the agreement, ... 240 WebWorld cyber stores in 105 cities to offer ... access to the Apollo Telemedicine Networking Foundation (ATNF), said ...
... Institute of Technology Sleep Laboratory had reported that children ... may need more sleep than others instead of drugs ... is considered an issue of over alertness and nervousness, ... the use of stimulant medications (such as Ritalin) has ...
... branded Zidovudine in US has lead to approval of FDA ... and can be imported from other countries. ,Zidovudine ... of AIDS, the drug prevents the replication of the virus ... The drug is also used in combination with other anti-retroviral ...
... disease which afflicts hundreds of elderly people may be a ... keep patients mentally agile and slow the crippling illness, say ... and not a normal process of ageing with phases of ... is past, the person slowly goes blank," N.M. Narula, president ...
... of the heart may be responsible for causing heart ... State University Dorothy M. Davis Heart and Lung Research ... (RyRs) malfunction in the failing heart. The RyRs form ... prevent the heart from contracting effectively and relaxing adequately. ...
Cached Medicine News:Health News:Children With ADHD May Just Be Sleepy 2Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2Health News:Defect In Cardiac Cells Lead To Heart Failures 2
... lead family features St. Jude ... The lead is available in ... and silicone (IsoFlex S lead) ... models, and multiple lead lengths, ...
... Veriteq's Refrigerator and Freezer Monitoring ... monitoring system for refrigerators and ... install. Using a building's existing ... Freezer monitoring solution automates the ...
Antiseptic - Antibacterial Sudsing Cleanser...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
Medicine Products: